比较Franseen针与Fork-tip针用于超声内镜引导下实性胰腺肿块细针活检取样的随机试验
该随机试验纳入50例胰腺肿块患者,均使用22G Franseen针和22G Fork-tip针进行超声内镜引导下取样,随机决定进针顺序。主要评估组织学核心组织面积,包括总组织、肿瘤、促结缔组织增生性纤维化面积及保留组织结构比例。结果显示两种针在上述指标及诊断性细胞块率、快速现场评估诊断充足率上均无显著差异。
要点
- Franseen针与Fork-tip针获取的总组织面积中位数分别为6.1 mm²和8.2 mm²,差异无统计学意义(P=.50)。
- 两种针的诊断性细胞块率分别为96.0%和92.0%,快速现场评估诊断充足率分别为94.0%和98.0%,均无显著差异。
- 作者认为新一代细针活检针诊断性细胞块获取率超过90%,可能无需快速现场评估。
核心结论
- Franseen针与Fork-tip针在获取组织学组织方面无显著差异,新一代细针活检针诊断性细胞块获取率超过90%,可能无需快速现场评估。
研究设计与样本
- 随机试验纳入50例接受超声内镜引导下胰腺肿块取样的患者,均使用22G Franseen针和22G Fork-tip针,随机决定进针顺序,每种针各进行2次专用穿刺用于细胞块,随后交替使用两种针进行快速现场评估穿刺直至确立诊断。
主要发现
- 总组织面积中位数Franseen针6.1 mm²(四分位距3.5-10.5)vs Fork-tip针8.2 mm²(四分位距4.0-13.0),P=.50。
- 肿瘤面积中位数Franseen针0.9 mm²(四分位距0.3-2.8)vs Fork-tip针1.0 mm²(四分位距0.4-2.7),P=.33。
- 促结缔组织增生性纤维化面积中位数Franseen针4.3 mm²(四分位距2.0-6.7)vs Fork-tip针5.2 mm²(四分位距1.7-6.1),P=.71。
- 保留组织结构比例Franseen针100% vs Fork-tip针83%,P=.25;诊断性细胞块率Franseen针96.0% vs Fork-tip针92.0%,P=.32;快速现场评估诊断充足率Franseen针94.0% vs Fork-tip针98.0%,P=.32。
- 最终诊断:胰腺癌44例,神经内分泌肿瘤2例,淋巴瘤1例,慢性胰腺炎3例。
临床怎么用
- 作者认为新一代细针活检针诊断性细胞块获取率超过90%,可能无需快速现场评估。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Recently, a 3-plane symmetric needle with Franseen geometry and a Fork-tip biopsy needle have been developed for histologic tissue procurement. We compared 22-gauge Franseen and 22-gauge Fork-tip needles in patients undergoing EUS-guided sampling of pancreatic masses. METHODS: Fifty patients underwent sampling using both 22-gauge Franseen and 22-gauge Fork-tip needles, with randomization of needle order. Two dedicated passes were performed using both needles for cell block. Subsequent passes were performed for rapid onsite evaluation (ROSE) using both needles alternately until diagnosis was established. The main outcome was to evaluate for histologic core tissue by comparing area of total tissue, tumor, desmoplastic fibrosis, and rate of retained tissue architecture between cohorts. Other outcomes were rates of diagnostic cell block and diagnostic adequacy at ROSE. RESULTS: Final diagnosis was pancreatic cancer in 44 patients, neuroendocrine tumor in 2, lymphoma in 1, and chronic pancreatitis in 3. There was no significant difference in area of total tissue (median 6.1 [interquartie range {IQR}, 3.5-10.5] vs 8.2 mm2 [IQR, 4.0-13.0], P = .50), tumor (median .9 [IQR .3-2.8] vs 1.0 mm2 [IQR .4-2.7], P = .33), desmoplastic fibrosis (median 4.3 [IQR, 2.0-6.7] vs 5.2 mm2 [IQR, 1.7-6.1], P = .71), retained architecture (100% vs 83%, P = .25), diagnostic cell block (96.0% vs 92.0%, P = .32), and diagnostic adequacy at ROSE (94.0% vs 98.0%, P = .32) between Franseen and Fork-tip needles, respectively. CONCLUSIONS: There was no significant difference between Franseen and Fork-tip needles in yielding histologic tissue. Given their ability to yield diagnostic cell block in greater than 90% of patients, the new-generation fine-needle biopsy needles may obviate the need for ROSE. (Clinical trial registration number: NCT02910960.).
引用
- Bang JY, Hebert-Magee S, Navaneethan U, et al. Randomized trial comparing the Franseen and Fork-tip needles for EUS-guided fine-needle biopsy sampling of solid pancreatic mass lesions. Gastrointest Endosc. 2018. PMID: 29305893. doi:10.1016/j.gie.2017.11.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。